Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial*Jennifer Tom, Fang Cai, Min Bao et al.|Critical Care Medicine|2021Cited by 42
Translational PK/PD for the Development of Novel Antibiotics—A Drug Developer’s PerspectiveCaterina Bissantz, William Stubbings, Lotte Winther et al.|Antibiotics|2024Cited by 11
Prognostic and predictive biomarkers in patients with COVID-19 treated with tocilizumab in a randomised controlled trialJennifer Tom, Fang Cai, Min Bao et al.|medRxiv|2020Cited by 5